-+ 0.00%
-+ 0.00%
-+ 0.00%

CELLTRION ANNOUNCES U.S. FDA APPROVAL OF 300MG STRENGTH OF OMLYCLO® (OMALIZUMAB-IGEC), THE FIRST AND ONLY FDA-APPROVED INTERCHANGEABLE BIOSIMILAR TO XOLAIR®

Reuters·12/03/2025 00:43:25

Please log in to view news